Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Tanaka, M; Okada, K; Ueshima, S; Imano, M; Ohyanagi, H; Carmeliet, P; Matsuo, O
   Impaired liver regeneration after partial hepatectomy in plasminogen deficient mice
   FIBRINOLYSIS & PROTEOLYSIS
   
   M. Tanaka et al., "Impaired liver regeneration after partial hepatectomy in plasminogen deficient mice", FIBRINOL PR, 15(1), 2001, pp. 2-8
2. Carmeliet, P; Conway, EM
   Growing better blood vessels - A polymer scaffold that delivers two angiogenic factors with distinct kinetics shows promise for engineering mature blood vessels
   NATURE BIOTECHNOLOGY
   
   P. Carmeliet e E.M. Conway, "Growing better blood vessels - A polymer scaffold that delivers two angiogenic factors with distinct kinetics shows promise for engineering mature blood vessels", NAT BIOTECH, 19(11), 2001, pp. 1019-1020
3. Nuyens, D; Stengl, M; Dugarmaa, S; Rossenbacker, T; Compernolle, V; Rudy, Y; Smits, JF; Flameng, W; Clancy, CE; Moons, L; Vos, MA; Dewerchin, M; Benndorf, K; Collen, D; Carmeliet, E; Carmeliet, P
   Abrupt rate accelerations or premature beats cause life-threatening arrhythmias in mice with long-QT3 syndrome
   NATURE MEDICINE
   
   D. Nuyens et al., "Abrupt rate accelerations or premature beats cause life-threatening arrhythmias in mice with long-QT3 syndrome", NAT MED, 7(9), 2001, pp. 1021-1027
4. Brown, EB; Campbell, RB; Tsuzuki, Y; Xu, L; Carmeliet, P; Fukumura, D; Jain, RK
   In vivo measurement of gene expression, angiogenesis and physiological function in tumors using multiphoton laser scanning microscopy (vol 7, pg 864,2001)
   NATURE MEDICINE
   
   E.B. Brown et al., "In vivo measurement of gene expression, angiogenesis and physiological function in tumors using multiphoton laser scanning microscopy (vol 7, pg 864,2001)", NAT MED, 7(9), 2001, pp. 1069-1069
5. Brown, EB; Campbell, RB; Tsuzuki, Y; Xu, L; Carmeliet, P; Fukumura, D; Jain, RK
   In vivo measurement of gene expression, angiogenesis and physiological function in tumors using multiphoton laser scanning microscopy
   NATURE MEDICINE
   
   E.B. Brown et al., "In vivo measurement of gene expression, angiogenesis and physiological function in tumors using multiphoton laser scanning microscopy", NAT MED, 7(7), 2001, pp. 866-870
6. Carmeliet, P; Moons, L; Luttun, A; Vincenti, V; Compernolle, V; De Mol, M; Wu, Y; Bon, F; Devy, L; Beck, H; Scholz, D; Acker, T; DiPalma, T; Dewerchin, M; Noel, A; Stalmans, I; Barra, A; Blacher, S; Vandendriessche, T; Ponten, A; Eriksson, U; Plate, KH; Foidart, JM; Schaper, W; Charnock-Jones, DS; Hicklin, DJ; Herbert, JM; Collen, D; Persico, MG
   Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathologicalconditions
   NATURE MEDICINE
   
   P. Carmeliet et al., "Synergism between vascular endothelial growth factor and placental growth factor contributes to angiogenesis and plasma extravasation in pathologicalconditions", NAT MED, 7(5), 2001, pp. 575-583
7. Angelillo-Scherrer, A; de Frutos, PG; Aparicio, C; Melis, E; Savi, P; Lupu, F; Arnout, J; Dewerchin, M; Hoylaerts, MF; Herbert, M; Collen, D; Dahlback, B; Carmeliet, P
   Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis
   NATURE MEDICINE
   
   A. Angelillo-Scherrer et al., "Deficiency or inhibition of Gas6 causes platelet dysfunction and protects mice against thrombosis", NAT MED, 7(2), 2001, pp. 215-221
8. Carmeliet, P
   Jeffrey Michael Isner 1947-2001 - Obituary
   NATURE MEDICINE
   
   P. Carmeliet, "Jeffrey Michael Isner 1947-2001 - Obituary", NAT MED, 7(12), 2001, pp. 1269-1269
9. Nicole, O; Docagne, F; Ali, C; Margaill, I; Carmeliet, P; MacKenzie, ET; Vivien, D; Buisson, A
   The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling
   NATURE MEDICINE
   
   O. Nicole et al., "The proteolytic activity of tissue-plasminogen activator enhances NMDA receptor-mediated signaling", NAT MED, 7(1), 2001, pp. 59-64
10. Oosthuyse, B; Moons, L; Storkebaum, E; Beck, H; Nuyens, D; Brusselmans, K; Van Dorpe, J; Hellings, P; Gorselink, M; Heymans, S; Theilmeier, G; Dewerchin, M; Laudenbach, V; Vermylen, P; Raat, H; Acker, T; Vleminckx, V; Van den Bosch, L; Cashman, N; Fujisawa, H; Drost, MR; Sciot, R; Bruyninckx, F; Hicklin, DJ; Ince, C; Gressens, P; Lupu, F; Plate, KH; Robberecht, W; Herbert, JM; Collen, D; Carmeliet, P
    Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration
    NATURE GENETICS
    
    B. Oosthuyse et al., "Deletion of the hypoxia-response element in the vascular endothelial growth factor promoter causes motor neuron degeneration", NAT GENET, 28(2), 2001, pp. 131-138
11. Dor, Y; Camenisch, T; Itin, A; Fishman, GI; McDonald, JA; Carmeliet, P; Keshet, E
    A novel role for VEGF in endocardial cushion formation and its potential contribution to congenital heart defects
    DEVELOPMENT
    
    Y. Dor et al., "A novel role for VEGF in endocardial cushion formation and its potential contribution to congenital heart defects", DEVELOPMENT, 128(9), 2001, pp. 1531-1538
12. Lambert, V; Munaut, C; Noel, A; Frankenne, F; Bajou, K; Gerard, R; Carmeliet, P; Defresne, MP; Foidart, JM; Rakic, JM
    Influence of plasminogen activator inhibitor type 1 on choroidal neovascularization
    FASEB JOURNAL
    
    V. Lambert et al., "Influence of plasminogen activator inhibitor type 1 on choroidal neovascularization", FASEB J, 15(6), 2001, pp. 1021-1027
13. Rajantie, I; Ekman, N; Iljin, K; Arighi, E; Gunji, Y; Kaukonen, J; Palotie, A; Dewerchin, M; Carmeliet, P; Alitalo, K
    Bmx tyrosine kinase has a redundant function downstream of angiopoietin and vascular endothelial growth factor receptors in arterial endothelium
    MOLECULAR AND CELLULAR BIOLOGY
    
    I. Rajantie et al., "Bmx tyrosine kinase has a redundant function downstream of angiopoietin and vascular endothelial growth factor receptors in arterial endothelium", MOL CELL B, 21(14), 2001, pp. 4647-4655
14. Holst-Hansen, C; Low, JA; Stephens, RW; Johnson, MD; Carmeliet, P; Frandsen, TL; Brunner, N; Dickson, RB
    Increased stromal expression of murine urokinase plasminogen activator in a human breast cancer xenograft model following treatment with the matrix metalloprotease inhibitor, batimastat
    BREAST CANCER RESEARCH AND TREATMENT
    
    C. Holst-Hansen et al., "Increased stromal expression of murine urokinase plasminogen activator in a human breast cancer xenograft model following treatment with the matrix metalloprotease inhibitor, batimastat", BREAST CANC, 68(3), 2001, pp. 225-237
15. Carmeliet, P
    Cardiovascular biology - Creating unique blood vessels
    NATURE
    
    P. Carmeliet, "Cardiovascular biology - Creating unique blood vessels", NATURE, 412(6850), 2001, pp. 868-869
16. Van Cromphaut, SJ; Dewerchin, M; Hoenderop, JGJ; Stockmans, I; Van Herck, E; Kato, S; Bindels, RJM; Collen, D; Carmeliet, P; Bouillon, R; Carmeliet, G
    Duodenal calcium absorption in vitamin D receptor-knockout mice: Functional and molecular aspects
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    
    S.J. Van Cromphaut et al., "Duodenal calcium absorption in vitamin D receptor-knockout mice: Functional and molecular aspects", P NAS US, 98(23), 2001, pp. 13324-13329
17. Yang, YH; Carmeliet, P; Hamilton, JA
    Tissue-type plasminogen activator deficiency exacerbates arthritis
    JOURNAL OF IMMUNOLOGY
    
    Y.H. Yang et al., "Tissue-type plasminogen activator deficiency exacerbates arthritis", J IMMUNOL, 167(2), 2001, pp. 1047-1052
18. Bajou, K; Masson, V; Gerard, RD; Schmitt, PM; Albert, V; Praus, M; Lund, LR; Frandsen, TL; Brunner, N; Dano, K; Fusenig, NE; Weidle, U; Carmeliet, G; Loskutoff, D; Collen, D; Carmeliet, P; Foidart, JM; Noel, AS
    The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin: Implications for antiangiogenic strategies
    JOURNAL OF CELL BIOLOGY
    
    K. Bajou et al., "The plasminogen activator inhibitor PAI-1 controls in vivo tumor vascularization by interaction with proteases, not vitronectin: Implications for antiangiogenic strategies", J CELL BIOL, 152(4), 2001, pp. 777-784
19. Brusselmans, K; Bono, F; Maxwell, P; Dor, Y; Dewerchin, M; Collen, D; Herbert, JM; Carmeliet, P
    Hypoxia-inducible factor-2 alpha (HIF-2 alpha) is involved in the apoptotic response to hypoglycemia but not to hypoxia
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    K. Brusselmans et al., "Hypoxia-inducible factor-2 alpha (HIF-2 alpha) is involved in the apoptotic response to hypoglycemia but not to hypoxia", J BIOL CHEM, 276(42), 2001, pp. 39192-39196
20. Yiou, R; Delmas, V; Carmeliet, P; Gherardi, RK; Barlovatz-Meimon, G; Chopin, DK; Abbou, CC; Lefaucheur, JP
    The pathophysiology of pelvic floor disorders: evidence from a histomorphologic study of the perineum and a mouse model of rectal prolapse
    JOURNAL OF ANATOMY
    
    R. Yiou et al., "The pathophysiology of pelvic floor disorders: evidence from a histomorphologic study of the perineum and a mouse model of rectal prolapse", J ANAT, 199, 2001, pp. 599-607
21. Heyen, MV; Heymans, S; Antoons, G; Reed, T; Periasamy, M; Awede, B; Lebacq, J; Vangheluwe, P; Dewerchin, M; Collen, D; Sipido, K; Carmeliet, P; Wuytack, F
    Replacement of the muscle-specific sarcoplasmic reticulum Ca2+-ATPase isoform SERCA2a by the nonmuscle SERCA2b homologue causes mild concentric hypertrophy and impairs contraction-relaxation of the heart
    CIRCULATION RESEARCH
    
    M.V. Heyen et al., "Replacement of the muscle-specific sarcoplasmic reticulum Ca2+-ATPase isoform SERCA2a by the nonmuscle SERCA2b homologue causes mild concentric hypertrophy and impairs contraction-relaxation of the heart", CIRCUL RES, 89(9), 2001, pp. 838-846
22. Levi, M; Moons, L; Bouche, A; Shapiro, SD; Collen, D; Carmeliet, P
    Deficiency of urokinase-type plasminogen activator-mediated plasmin generation impairs vascular remodeling during hypoxia-induced pulmonary hypertension in mice
    CIRCULATION
    
    M. Levi et al., "Deficiency of urokinase-type plasminogen activator-mediated plasmin generation impairs vascular remodeling during hypoxia-induced pulmonary hypertension in mice", CIRCULATION, 103(15), 2001, pp. 2014-2020
23. Conway, EM; Collen, D; Carmeliet, P
    Molecular mechanisms of blood vessel growth
    CARDIOVASCULAR RESEARCH
    
    E.M. Conway et al., "Molecular mechanisms of blood vessel growth", CARDIO RES, 49(3), 2001, pp. 507-521
24. Kadambi, A; Carreira, CM; Yun, C; Padera, TP; Dolmans, DEJGJ; Carmeliet, P; Fukumura, D; Jain, RK
    Vascular endothelial growth factor (VEGF)-C differentially affects tumor vascular function and leukocyte recruitment: Role of VEGF-receptor 2 and host VEGF-A
    CANCER RESEARCH
    
    A. Kadambi et al., "Vascular endothelial growth factor (VEGF)-C differentially affects tumor vascular function and leukocyte recruitment: Role of VEGF-receptor 2 and host VEGF-A", CANCER RES, 61(6), 2001, pp. 2404-2408
25. Frandsen, TL; Holst-Hansen, C; Nielsen, BS; Christensen, IJ; Nyengaard, JR; Carmeliet, P; Brunner, N
    Direct evidence of the importance of stromal urokinase plasminogen activator (uPA) fin the growth of an experimental human breast cancer using a combined uPA gene-disrupted and immunodeficient xenograft model
    CANCER RESEARCH
    
    T.L. Frandsen et al., "Direct evidence of the importance of stromal urokinase plasminogen activator (uPA) fin the growth of an experimental human breast cancer using a combined uPA gene-disrupted and immunodeficient xenograft model", CANCER RES, 61(2), 2001, pp. 532-537
26. Lluis, F; Roma, J; Suelves, M; Parra, M; Aniorte, G; Gallardo, E; Illa, I; Rodriguez, L; Hughes, SM; Carmeliet, P; Roig, M; Munoz-Canoves, P
    Urokinase-dependent plasminogen activation is required for efficient skeletal muscle regeneration in vivo
    BLOOD
    
    F. Lluis et al., "Urokinase-dependent plasminogen activation is required for efficient skeletal muscle regeneration in vivo", BLOOD, 97(6), 2001, pp. 1703-1711
27. Melis, E; Moons, L; De Mol, M; Herbert, JM; Mackman, N; Collen, D; Carmeliet, P; Dewerchin, M
    Targeted deletion of the cytosolic domain of tissue factor in mice does not affect development
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    
    E. Melis et al., "Targeted deletion of the cytosolic domain of tissue factor in mice does not affect development", BIOC BIOP R, 286(3), 2001, pp. 580-586
28. Herbert, JM; de Prost, D; Ollivier, V; Melis, E; Carmeliet, P
    Tissue factor is not involved in the mitogenic activity of factor VIIa
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
    
    J.M. Herbert et al., "Tissue factor is not involved in the mitogenic activity of factor VIIa", BIOC BIOP R, 281(5), 2001, pp. 1074-1077
29. Yu, JL; Rak, JW; Carmeliet, P; Nagy, A; Kerbel, RS; Coomber, BL
    Heterogeneous vascular dependence of tumor cell populations
    AMERICAN JOURNAL OF PATHOLOGY
    
    J.L. Yu et al., "Heterogeneous vascular dependence of tumor cell populations", AM J PATH, 158(4), 2001, pp. 1325-1334
30. Carmeliet, P
    Mechanisms of angiogenesis and arteriogenesis
    NATURE MEDICINE
    
    P. Carmeliet, "Mechanisms of angiogenesis and arteriogenesis", NAT MED, 6(4), 2000, pp. 389-395
31. Li, J; Post, M; Volk, R; Gao, YH; Li, M; Metais, C; Sato, K; Tsai, J; Aird, W; Rosenberg, RD; Hampton, TG; Li, JY; Sellke, F; Carmeliet, P; Simons, M
    PR39, a peptide regulator of angiogenesis (vol 6, pg 49, 2000)
    NATURE MEDICINE
    
    J. Li et al., "PR39, a peptide regulator of angiogenesis (vol 6, pg 49, 2000)", NAT MED, 6(3), 2000, pp. 356-356
32. Carmeliet, P
    VEGF gene therapy: stimulating angiogenesis or angioma-genesis?
    NATURE MEDICINE
    
    P. Carmeliet, "VEGF gene therapy: stimulating angiogenesis or angioma-genesis?", NAT MED, 6(10), 2000, pp. 1102-1103
33. Li, J; Post, M; Volk, R; Gao, Y; Li, M; Metais, C; Sato, K; Tsai, J; Aird, W; Rosenberg, RD; Hampton, TG; Li, JY; Sellke, F; Carmeliet, P; Simons, M
    PR39, a peptide regulator of angiogenesis
    NATURE MEDICINE
    
    J. Li et al., "PR39, a peptide regulator of angiogenesis", NAT MED, 6(1), 2000, pp. 49-55
34. Dewerchin, M; Liang, Z; Moons, L; Carmeliet, P; Castellino, FJ; Collen, D; Rosen, ED
    Blood coagulation factor x deficiency causes partial embryonic lethality and fatal neonatal bleeding in mice
    THROMBOSIS AND HAEMOSTASIS
    
    M. Dewerchin et al., "Blood coagulation factor x deficiency causes partial embryonic lethality and fatal neonatal bleeding in mice", THROMB HAEM, 83(2), 2000, pp. 185-190
35. Jacquemin, P; Durviaux, SM; Jensen, J; Godfraind, C; Gradwohl, G; Guillemot, F; Madsen, OD; Carmeliet, P; Dewerchin, M; Collen, D; Rousseau, GG; Lemaigre, FP
    Transcription factor hepatocyte nuclear factor 6 regulates pancreatic endocrine cell differentiation and controls expression of the proendocrine genengn3
    MOLECULAR AND CELLULAR BIOLOGY
    
    P. Jacquemin et al., "Transcription factor hepatocyte nuclear factor 6 regulates pancreatic endocrine cell differentiation and controls expression of the proendocrine genengn3", MOL CELL B, 20(12), 2000, pp. 4445-4454
36. Carmeliet, P
    Developmental biology - One cell, two fates
    NATURE
    
    P. Carmeliet, "Developmental biology - One cell, two fates", NATURE, 408(6808), 2000, pp. 43-45
37. Carmeliet, P; Jain, RK
    Angiogenesis in cancer and other diseases
    NATURE
    
    P. Carmeliet e R.K. Jain, "Angiogenesis in cancer and other diseases", NATURE, 407(6801), 2000, pp. 249-257
38. Carmeliet, P; Collen, D
    Transgenic mouse models in angiogenesis and cardiovascular disease
    JOURNAL OF PATHOLOGY
    
    P. Carmeliet e D. Collen, "Transgenic mouse models in angiogenesis and cardiovascular disease", J PATHOLOGY, 190(3), 2000, pp. 387-405
39. Uhrin, P; Dewerchin, M; Hilpert, M; Chrenek, P; Schofer, C; Zechmeister-Machhart, M; Kronke, G; Vales, A; Carmeliet, P; Binder, BR; Geiger, M
    Disruption of the protein C inhibitor gene results in impaired spermatogenesis and male infertility
    JOURNAL OF CLINICAL INVESTIGATION
    
    P. Uhrin et al., "Disruption of the protein C inhibitor gene results in impaired spermatogenesis and male infertility", J CLIN INV, 106(12), 2000, pp. 1531-1539
40. Carmeliet, P
    Proteinases in cardiovascular aneurysms and rupture: targets for therapy?
    JOURNAL OF CLINICAL INVESTIGATION
    
    P. Carmeliet, "Proteinases in cardiovascular aneurysms and rupture: targets for therapy?", J CLIN INV, 105(11), 2000, pp. 1519-1520
41. Baes, M; Huyghe, S; Carmeliet, P; Declercq, PE; Collen, D; Mannaerts, GP; Van Veldhoven, PP
    Inactivation of the peroxisomal multifunctional protein-2 in mice impedes the degradation of not only 2-methyl-branched fatty acids and bile acid intermediates but also of very long chain fatty acids
    JOURNAL OF BIOLOGICAL CHEMISTRY
    
    M. Baes et al., "Inactivation of the peroxisomal multifunctional protein-2 in mice impedes the degradation of not only 2-methyl-branched fatty acids and bile acid intermediates but also of very long chain fatty acids", J BIOL CHEM, 275(21), 2000, pp. 16329-16336
42. Carmeliet, P
    Fibroblast growth factor-1 stimulates branching and survival of myocardialarteries - A goal for therapeutic angiogenesis?
    CIRCULATION RESEARCH
    
    P. Carmeliet, "Fibroblast growth factor-1 stimulates branching and survival of myocardialarteries - A goal for therapeutic angiogenesis?", CIRCUL RES, 87(3), 2000, pp. 176-178
43. Tsuzuki, Y; Fukumura, D; Oosthuyse, B; Koike, C; Carmeliet, P; Jain, RK
    Vascular endothelial growth factor (VEGF) modulation by targeting hypoxia-inducible factor-1 alpha -> hypoxia response element -> VEGF cascade differentially regulates vascular response and growth rate in tumors
    CANCER RESEARCH
    
    Y. Tsuzuki et al., "Vascular endothelial growth factor (VEGF) modulation by targeting hypoxia-inducible factor-1 alpha -> hypoxia response element -> VEGF cascade differentially regulates vascular response and growth rate in tumors", CANCER RES, 60(22), 2000, pp. 6248-6252
44. Kataoka, K; Asai, T; Taneda, M; Ueshima, S; Matsuo, O; Kuroda, R; Kawabata, A; Carmeliet, P
    Roles of urokinase type plasminogen activator in a brain stab wound
    BRAIN RESEARCH
    
    K. Kataoka et al., "Roles of urokinase type plasminogen activator in a brain stab wound", BRAIN RES, 887(1), 2000, pp. 187-190
45. Bautch, VL; Redick, SD; Scalia, A; Harmaty, M; Carmeliet, P; Rapoport, R
    Characterization of the vasculogenic block in the absence of vascular endothelial growth factor-A
    BLOOD
    
    V.L. Bautch et al., "Characterization of the vasculogenic block in the absence of vascular endothelial growth factor-A", BLOOD, 95(6), 2000, pp. 1979-1987
46. Creemers, E; Cleutjens, J; Smits, J; Heymans, S; Moons, L; Collen, D; Daemen, M; Carmeliet, P
    Disruption of the plasminogen gene in mice abolishes wound healing after myocardial infarction
    AMERICAN JOURNAL OF PATHOLOGY
    
    E. Creemers et al., "Disruption of the plasminogen gene in mice abolishes wound healing after myocardial infarction", AM J PATH, 156(6), 2000, pp. 1865-1873
47. Noel, A; Bajou, K; Masson, V; Devy, L; Frankenne, F; Rakic, JM; Lambert, V; Carmeliet, P; Foidart, JM
    Regulation of cancer invasion and vascularization by plasminogen activatorinhibitor-1
    FIBRINOLYSIS & PROTEOLYSIS
    
    A. Noel et al., "Regulation of cancer invasion and vascularization by plasminogen activatorinhibitor-1", FIBRINOL PR, 13(6), 1999, pp. 220-225
48. Plow, EF; Ploplis, VA; Carmeliet, P; Collen, D
    Plasminogen and cell migration in vivo
    FIBRINOLYSIS & PROTEOLYSIS
    
    E.F. Plow et al., "Plasminogen and cell migration in vivo", FIBRINOL PR, 13(2), 1999, pp. 49-53
49. Hansson, G; Carmeliet, P; Pepper, M
    Tribute to Werner Risau - December 18, 1953 December 13, 1998 - In Memoriam
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    
    G. Hansson et al., "Tribute to Werner Risau - December 18, 1953 December 13, 1998 - In Memoriam", ART THROM V, 19(4), 1999, pp. 829-829
50. Tabrizi, P; Wang, L; Seeds, N; McComb, JG; Yamada, S; Griffin, JH; Carmeliet, P; Weiss, MH; Zlokovic, BV
    Tissue plasminogen activator (tPA) deficiency exacerbates cerebrovascular fibrin deposition and brain injury in a murine stroke model - Studies in tPA-deficient mice and wild-type mice on a matched genetic background
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY
    
    P. Tabrizi et al., "Tissue plasminogen activator (tPA) deficiency exacerbates cerebrovascular fibrin deposition and brain injury in a murine stroke model - Studies in tPA-deficient mice and wild-type mice on a matched genetic background", ART THROM V, 19(11), 1999, pp. 2801-2806
51. Carmeliet, P; Ng, YS; Nuyens, D; Theilmeier, G; Brusselmans, K; Cornelissen, I; Ehler, E; Kakkar, VV; Stalmans, I; Mattot, V; Perriard, JC; Dewerchin, M; Flameng, W; Nagy, A; Lupu, F; Moons, L; Collen, D; D'Amore, PA; Shima, DT
    Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF(164) and VEGF(188)
    NATURE MEDICINE
    
    P. Carmeliet et al., "Impaired myocardial angiogenesis and ischemic cardiomyopathy in mice lacking the vascular endothelial growth factor isoforms VEGF(164) and VEGF(188)", NAT MED, 5(5), 1999, pp. 495-502
52. Heymans, S; Luttun, A; Nuyens, D; Theilmeier, G; Creemers, E; Moons, L; Dyspersin, GD; Cleutjens, JPM; Shipley, M; Angellilo, A; Levi, M; Nube, O; Baker, A; Keshet, E; Lupu, F; Herbert, JM; Smits, JFM; Shapiro, SD; Baes, M; Borgers, M; Collen, D; Daemen, MJAP; Carmeliet, P
    Inhibition of plasminogen activators or matrix metalloproteinases preventscardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure
    NATURE MEDICINE
    
    S. Heymans et al., "Inhibition of plasminogen activators or matrix metalloproteinases preventscardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure", NAT MED, 5(10), 1999, pp. 1135-1142
53. Lijnen, HR; Lupu, F; Moons, L; Carmeliet, P; Goulding, D; Collen, D
    Temporal and topographic matrix metalloproteinase expression after vascular injury in mice
    THROMBOSIS AND HAEMOSTASIS
    
    H.R. Lijnen et al., "Temporal and topographic matrix metalloproteinase expression after vascular injury in mice", THROMB HAEM, 81(5), 1999, pp. 799-807
54. Kataoka, K; Asai, T; Taneda, M; Ueshima, S; Matsuo, O; Kuroda, R; Carmeliet, P; Collen, D
    Nigral degeneration following striato-pallidal lesion in tissue type plasminogen activator deficient mice
    NEUROSCIENCE LETTERS
    
    K. Kataoka et al., "Nigral degeneration following striato-pallidal lesion in tissue type plasminogen activator deficient mice", NEUROSCI L, 266(3), 1999, pp. 220-222
55. Carmeliet, P; Lampugnani, MG; Moons, L; Breviario, F; Compernolle, V; Bono, F; Balconi, G; Spagnuolo, R; Oosthuyse, B; Dewerchin, M; Zanetti, A; Angellilo, A; Mattot, V; Nuyens, D; Lutgens, E; Clotman, F; de Ruiter, MC; Gittenberger-de Groot, A; Poelmann, R; Lupu, F; Herbert, JM; Collen, D; Dejana, E
    Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis
    CELL
    
    P. Carmeliet et al., "Targeted deficiency or cytosolic truncation of the VE-cadherin gene in mice impairs VEGF-mediated endothelial survival and angiogenesis", CELL, 98(2), 1999, pp. 147-157
56. Carmeliet, P; Collen, D
    New developments in the molecular biology of coagulation and fibrinolysis
    ANTITHROMBOTICS
    
    P. Carmeliet e D. Collen, "New developments in the molecular biology of coagulation and fibrinolysis", HANDB EXP P, 132, 1999, pp. 41-76
57. Carmeliet, P; Collen, D
    Role of vascular endothelial growth factor and vascular endothelial growthfactor receptors in vascular development
    VASCULAR GROWTH FACTORS AND ANGIOGENESIS
    
    P. Carmeliet e D. Collen, "Role of vascular endothelial growth factor and vascular endothelial growthfactor receptors in vascular development", CURR T MICR, 237, 1999, pp. 133-158
58. Carmeliet, P
    Developmental biology - Controlling the cellular brakes
    NATURE
    
    P. Carmeliet, "Developmental biology - Controlling the cellular brakes", NATURE, 401(6754), 1999, pp. 657-658
59. Erlich, J; Parry, GCN; Fearns, C; Muller, M; Carmeliet, P; Luther, T; Mackman, N
    Tissue factor is required for uterine hemostasis and maintenance of the placental labyrinth during gestation
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
    
    J. Erlich et al., "Tissue factor is required for uterine hemostasis and maintenance of the placental labyrinth during gestation", P NAS US, 96(14), 1999, pp. 8138-8143
60. Chan, JCY; Carmeliet, P; Moons, L; Rosen, ED; Huang, ZF; Broze, GJ; Collen, D; Castellino, FJ
    Factor VII deficiency rescues the intrauterine lethality in mice associated with a tissue factor pathway inhibitor deficit
    JOURNAL OF CLINICAL INVESTIGATION
    
    J.C.Y. Chan et al., "Factor VII deficiency rescues the intrauterine lethality in mice associated with a tissue factor pathway inhibitor deficit", J CLIN INV, 103(4), 1999, pp. 475-482
61. Ny, A; Leonardsson, G; Hagglund, AC; Hagglof, P; Ploplis, VA; Carmeliet, P; Ny, T
    Ovulation in plasminogen-deficient mice
    ENDOCRINOLOGY
    
    A. Ny et al., "Ovulation in plasminogen-deficient mice", ENDOCRINOL, 140(11), 1999, pp. 5030-5035
62. Shi, CW; Patel, A; Zhang, D; Wang, H; Carmeliet, P; Reed, GL; Lee, ME; Haber, E; Sibinga, NES
    Plasminogen is not required for neointima formation in a mouse model of vein graft stenosis
    CIRCULATION RESEARCH
    
    C.W. Shi et al., "Plasminogen is not required for neointima formation in a mouse model of vein graft stenosis", CIRCUL RES, 84(8), 1999, pp. 883-890
63. Zhu, YH; Carmeliet, P; Fay, WP
    Plasminogen activator inhibitor-1 is a major determinant of arterial thrombolysis resistance
    CIRCULATION
    
    Y.H. Zhu et al., "Plasminogen activator inhibitor-1 is a major determinant of arterial thrombolysis resistance", CIRCULATION, 99(23), 1999, pp. 3050-3055
64. Nagai, N; De Mol, M; Lijnen, HR; Carmeliet, P; Collen, D
    Role of plasminogen system components in focal cerebral ischemic infarction - A gene targeting and gene transfer study in mice
    CIRCULATION
    
    N. Nagai et al., "Role of plasminogen system components in focal cerebral ischemic infarction - A gene targeting and gene transfer study in mice", CIRCULATION, 99(18), 1999, pp. 2440-2444
65. Conway, EM; Pollefeyt, S; Cornelissen, J; DeBaere, I; Steiner-Mosonyi, M; Weitz, JI; Weiler-Guettler, H; Carmeliet, P; Collen, D
    Structure-function analyses of thrombomodulin by gene-targeting in mice: The cytoplasmic domain is not required for normal fetal development
    BLOOD
    
    E.M. Conway et al., "Structure-function analyses of thrombomodulin by gene-targeting in mice: The cytoplasmic domain is not required for normal fetal development", BLOOD, 93(10), 1999, pp. 3442-3450
66. Carmeliet, P; Collen, D
    Targeted gene manipulation and gene transfer to study vascular biology
    MODERN VISUALISATION OF THE ENDOTHELIUM
    
    P. Carmeliet e D. Collen, "Targeted gene manipulation and gene transfer to study vascular biology", EN CEL RE S, 4, 1998, pp. 189-234
67. HERBERT JM; CARMELIET P
    UROKINASE MEDIATES BFGF-INDUCED VASCULAR SMOOTH-MUSCLE CELL-MIGRATIONUNDER THE CONTROL OF TGF-BETA
    FIBRINOLYSIS & PROTEOLYSIS
    
    J.M. Herbert e P. Carmeliet, "UROKINASE MEDIATES BFGF-INDUCED VASCULAR SMOOTH-MUSCLE CELL-MIGRATIONUNDER THE CONTROL OF TGF-BETA", FIBRINOLYSIS & PROTEOLYSIS, 12(2), 1998, pp. 89-96
68. CARMELIET P; COLLEN D
    MOLECULES IN FOCUS - TISSUE FACTOR
    International journal of biochemistry & cell biology
    
    P. Carmeliet e D. Collen, "MOLECULES IN FOCUS - TISSUE FACTOR", International journal of biochemistry & cell biology, 30(6), 1998, pp. 661-667
69. LIJNEN HR; VANHOEF B; LUPU F; MOONS L; CARMELIET P; COLLEN D
    FUNCTION OF THE PLASMINOGEN PLASMIN AND MATRIX METALLOPROTEINASE SYSTEMS AFTER VASCULAR INJURY IN MICE WITH TARGETED INACTIVATION OF FIBRINOLYTIC SYSTEM GENES/
    Arteriosclerosis, thrombosis, and vascular biology
    
    H.R. Lijnen et al., "FUNCTION OF THE PLASMINOGEN PLASMIN AND MATRIX METALLOPROTEINASE SYSTEMS AFTER VASCULAR INJURY IN MICE WITH TARGETED INACTIVATION OF FIBRINOLYTIC SYSTEM GENES/", Arteriosclerosis, thrombosis, and vascular biology, 18(7), 1998, pp. 1035-1045
70. BAJOU K; NOEL A; GERARD RD; MASSON V; BRUNNER N; HOLSTHANSEN C; SKOBE M; FUSENIG NE; CARMELIET P; COLLEN D; FOIDART JM
    ABSENCE OF HOST PLASMINOGEN-ACTIVATOR INHIBITOR-1 PREVENTS CANCER INVASION AND VASCULARIZATION
    Nature medicine
    
    K. Bajou et al., "ABSENCE OF HOST PLASMINOGEN-ACTIVATOR INHIBITOR-1 PREVENTS CANCER INVASION AND VASCULARIZATION", Nature medicine, 4(8), 1998, pp. 923-928
71. LIANG Z; COOPER A; DEFORD ME; CARMELIET P; COLLEN D; CASTELLINO FJ; ROSEN ED
    CLONING AND CHARACTERIZATION OF A CDNA-ENCODING MURINE COAGULATION-FACTOR-X
    Thrombosis and haemostasis
    
    Z. Liang et al., "CLONING AND CHARACTERIZATION OF A CDNA-ENCODING MURINE COAGULATION-FACTOR-X", Thrombosis and haemostasis, 80(1), 1998, pp. 87-91
72. JALBERT LR; ELLIOT D; LISSENS A; CARMELIET P; COLLEN D; CASTELLINO FJ
    NUCLEOTIDE STRUCTURE AND CHARACTERIZATION OF THE MURINE GENE ENCODINGANTICOAGULANT PROTEIN-C
    Thrombosis and haemostasis
    
    L.R. Jalbert et al., "NUCLEOTIDE STRUCTURE AND CHARACTERIZATION OF THE MURINE GENE ENCODINGANTICOAGULANT PROTEIN-C", Thrombosis and haemostasis, 79(2), 1998, pp. 310-316
73. CREEMERS EEJM; DAEMEN MJAP; CLEUTJENS JPM; SMITS JFM; MOONS L; COLLEN D; CARMELIET P
    PLASMINOGEN DEFICIENCY LEADS TO STAGNANT WOUND-HEALING FOLLOWING MYOCARDIAL-INFARCTION IN MICE
    Hypertension
    
    E.E.J.M. Creemers et al., "PLASMINOGEN DEFICIENCY LEADS TO STAGNANT WOUND-HEALING FOLLOWING MYOCARDIAL-INFARCTION IN MICE", Hypertension, 32(4), 1998, pp. 105-105
74. CARMELIET P; COLLEN D
    VASCULAR DEVELOPMENT AND DISORDERS - MOLECULAR ANALYSIS AND PATHOGENIC INSIGHTS
    Kidney international
    
    P. Carmeliet e D. Collen, "VASCULAR DEVELOPMENT AND DISORDERS - MOLECULAR ANALYSIS AND PATHOGENIC INSIGHTS", Kidney international, 53(6), 1998, pp. 1519-1549
75. CARMELIET P; COLLEN D
    DEVELOPMENT AND DISEASE IN PROTEINASE-DEFICIENT MICE - ROLE OF THE PLASMINOGEN, MATRIX METALLOPROTEINASE AND COAGULATION SYSTEM
    Thrombosis research
    
    P. Carmeliet e D. Collen, "DEVELOPMENT AND DISEASE IN PROTEINASE-DEFICIENT MICE - ROLE OF THE PLASMINOGEN, MATRIX METALLOPROTEINASE AND COAGULATION SYSTEM", Thrombosis research, 91(6), 1998, pp. 255-285
76. CARMELIET P; DOR Y; HERBERT JM; FUKUMURA D; BRUSSELMANS K; DEWERCHIN M; NEEMAN M; BONO F; ABRAMOVITCH R; MAXWELL P; KOCH CJ; RATCLIFFE P; MOONS L; JAIN RK; COLLEN D; KESHERT E
    ROLE OF HIF-1-ALPHA IN HYPOXIA-MEDIATED APOPTOSIS, CELL-PROLIFERATIONAND TUMOR ANGIOGENESIS (VOL 394, PG 485, 1998)
    Nature
    
    P. Carmeliet et al., "ROLE OF HIF-1-ALPHA IN HYPOXIA-MEDIATED APOPTOSIS, CELL-PROLIFERATIONAND TUMOR ANGIOGENESIS (VOL 394, PG 485, 1998)", Nature, 395(6701), 1998, pp. 525-525
77. CARMELIET P; DOR Y; HERBERT JM; FUKUMURA D; BRUSSELMANS K; DEWERCHIN M; NEEMAN M; BONO F; ABRAMOVITCH R; MAXWELL P; KOCH CJ; RATCLIFFE P; MOONS L; JAIN RK; COLLEN D; KESHET E
    ROLE OF HIF-1-ALPHA OR IN HYPOXIA-MEDIATED APOPTOSIS, CELL-PROLIFERATION AND TUMOR ANGIOGENESIS
    Nature
    
    P. Carmeliet et al., "ROLE OF HIF-1-ALPHA OR IN HYPOXIA-MEDIATED APOPTOSIS, CELL-PROLIFERATION AND TUMOR ANGIOGENESIS", Nature, 394(6692), 1998, pp. 485-490
78. CARMELIET P
    MOLECULAR ANALYSIS, VIA GENE TARGETING AND GENE-TRANSFER, OF BLOOD-VESSEL FORMATION AND DISORDERS
    Journal of physiology
    
    P. Carmeliet, "MOLECULAR ANALYSIS, VIA GENE TARGETING AND GENE-TRANSFER, OF BLOOD-VESSEL FORMATION AND DISORDERS", Journal of physiology, 506P, 1998, pp. 19-19
79. JENSEN PJ; CARMELIET P; COLLEN D; LAVKER RM
    UROKINASE PLASMINOGEN-ACTIVATOR PROMOTES KERATINOCYTE PROLIFERATION IN-VIVO
    Journal of investigative dermatology
    
    P.J. Jensen et al., "UROKINASE PLASMINOGEN-ACTIVATOR PROMOTES KERATINOCYTE PROLIFERATION IN-VIVO", Journal of investigative dermatology, 110(4), 1998, pp. 492-492
80. JALBERT LR; ROSEN ED; MOONS L; CHAN JCY; CARMELIET P; COLLEN D; CASTELLINO FJ
    INACTIVATION OF THE GENE FOR ANTICOAGULANT PROTEIN-C CAUSES LETHAL PERINATAL CONSUMPTIVE COAGULOPATHY IN MICE
    The Journal of clinical investigation
    
    L.R. Jalbert et al., "INACTIVATION OF THE GENE FOR ANTICOAGULANT PROTEIN-C CAUSES LETHAL PERINATAL CONSUMPTIVE COAGULOPATHY IN MICE", The Journal of clinical investigation, 102(8), 1998, pp. 1481-1488
81. PINSKY DJ; LIAO H; LAWSON CA; YAN SF; CHEN JX; CARMELIET P; LOSKUTOFF DJ; STERN DM
    COORDINATED INDUCTION OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) AND INHIBITION OF PLASMINOGEN-ACTIVATOR GENE-EXPRESSION BY HYPOXIA PROMOTES PULMONARY VASCULAR FIBRIN DEPOSITION
    The Journal of clinical investigation
    
    D.J. Pinsky et al., "COORDINATED INDUCTION OF PLASMINOGEN-ACTIVATOR INHIBITOR-1 (PAI-1) AND INHIBITION OF PLASMINOGEN-ACTIVATOR GENE-EXPRESSION BY HYPOXIA PROMOTES PULMONARY VASCULAR FIBRIN DEPOSITION", The Journal of clinical investigation, 102(5), 1998, pp. 919-928
82. MOONS L; SHI CW; PLOPLIS V; PLOW E; HABER E; COLLEN D; CARMELIET P
    REDUCED TRANSPLANT ARTERIOSCLEROSIS IN PLASMINOGEN-DEFICIENT MICE
    The Journal of clinical investigation
    
    L. Moons et al., "REDUCED TRANSPLANT ARTERIOSCLEROSIS IN PLASMINOGEN-DEFICIENT MICE", The Journal of clinical investigation, 102(10), 1998, pp. 1788-1797
83. PARRY GCN; ERLICH JH; CARMELIET P; LUTHER T; MACKMAN N
    LOW-LEVELS OF TISSUE FACTOR ARE COMPATIBLE WITH DEVELOPMENT AND HEMOSTASIS IN MICE
    The Journal of clinical investigation
    
    G.C.N. Parry et al., "LOW-LEVELS OF TISSUE FACTOR ARE COMPATIBLE WITH DEVELOPMENT AND HEMOSTASIS IN MICE", The Journal of clinical investigation, 101(3), 1998, pp. 560-569
84. CARMELIET P; MOONS L; DEWERCHIN M; ROSENBERG S; HERBERT JM; LUPU F; COLLEN D
    RECEPTOR-INDEPENDENT ROLE OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR IN PERICELLULAR PLASMIN AND MATRIX METALLOPROTEINASE PROTEOLYSIS DURING VASCULAR WOUND-HEALING IN MICE
    The Journal of cell biology
    
    P. Carmeliet et al., "RECEPTOR-INDEPENDENT ROLE OF UROKINASE-TYPE PLASMINOGEN-ACTIVATOR IN PERICELLULAR PLASMIN AND MATRIX METALLOPROTEINASE PROTEOLYSIS DURING VASCULAR WOUND-HEALING IN MICE", The Journal of cell biology, 140(1), 1998, pp. 233-245
85. CREEMERS EEJM; DAEMEN MJAP; CLEUTJENS JPM; SMITS JFM; MOONS L; COLLEN D; CARMELIET P
    COMPLETE INHIBITION OF CARDIAC WOUND-HEALING AFTER MYOCARDIAL-INFARCTION IN PLASMINOGEN DEFICIENT MICE
    Circulation
    
    E.E.J.M. Creemers et al., "COMPLETE INHIBITION OF CARDIAC WOUND-HEALING AFTER MYOCARDIAL-INFARCTION IN PLASMINOGEN DEFICIENT MICE", Circulation, 98(17), 1998, pp. 2910-2910
86. FARREHI PM; OZAKI CK; CARMELIET P; FAY WP
    REGULATION OF ARTERIAL THROMBOLYSIS BY PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN MICE
    Circulation
    
    P.M. Farrehi et al., "REGULATION OF ARTERIAL THROMBOLYSIS BY PLASMINOGEN-ACTIVATOR INHIBITOR-1 IN MICE", Circulation, 97(10), 1998, pp. 1002-1008
87. CARMELIET P; MOONS L; COLLEN D
    MOUSE MODELS OF ANGIOGENESIS, ARTERIAL-STENOSIS, ATHEROSCLEROSIS AND HEMOSTASIS
    Cardiovascular Research
    
    P. Carmeliet et al., "MOUSE MODELS OF ANGIOGENESIS, ARTERIAL-STENOSIS, ATHEROSCLEROSIS AND HEMOSTASIS", Cardiovascular Research, 39(1), 1998, pp. 8-33
88. PLOPLIS VA; FRENCH EL; CARMELIET P; COLLEN D; PLOW EF
    PLASMINOGEN DEFICIENCY DIFFERENTIALLY AFFECTS RECRUITMENT OF INFLAMMATORY CELL-POPULATIONS IN MICE
    Blood
    
    V.A. Ploplis et al., "PLASMINOGEN DEFICIENCY DIFFERENTIALLY AFFECTS RECRUITMENT OF INFLAMMATORY CELL-POPULATIONS IN MICE", Blood, 91(6), 1998, pp. 2005-2009
89. CARMELIET P
    INSIGHTS FROM GENE-INACTIVATION STUDIES OF THE COAGULATION AND PLASMINOGEN
    Fibrinolysis & proteolysis
    
    P. Carmeliet, "INSIGHTS FROM GENE-INACTIVATION STUDIES OF THE COAGULATION AND PLASMINOGEN", Fibrinolysis & proteolysis, 11, 1997, pp. 181-191
90. CARMELIET P; MOONS L; LIJNEN R; BAES M; LEMAITRE V; TIPPING P; DREW A; EECKHOUT Y; SHAPIRO S; LUPU F; COLLEN D
    UROKINASE-GENERATED PLASMIN ACTIVATES MATRIX METALLOPROTEINASES DURING ANEURYSM FORMATION
    Nature genetics
    
    P. Carmeliet et al., "UROKINASE-GENERATED PLASMIN ACTIVATES MATRIX METALLOPROTEINASES DURING ANEURYSM FORMATION", Nature genetics, 17(4), 1997, pp. 439-444
91. BAES M; GRESSENS P; BAUMGART E; CARMELIET P; CASTEELS M; FRANSEN M; EVRARD P; FAHIMI D; DECLERCQ PE; COLLEN D; VANVELDHOVEN PP; MANNAERTS GP
    A MOUSE MODEL FOR ZELLWEGER-SYNDROME
    Nature genetics
    
    M. Baes et al., "A MOUSE MODEL FOR ZELLWEGER-SYNDROME", Nature genetics, 17(1), 1997, pp. 49-57
92. CARMELIET P; COLLEN D
    GENETIC-ANALYSIS OF BLOOD-VESSEL FORMATION - ROLE OF ENDOTHELIAL VERSUS SMOOTH-MUSCLE CELLS
    Trends in cardiovascular medicine
    
    P. Carmeliet e D. Collen, "GENETIC-ANALYSIS OF BLOOD-VESSEL FORMATION - ROLE OF ENDOTHELIAL VERSUS SMOOTH-MUSCLE CELLS", Trends in cardiovascular medicine, 7(8), 1997, pp. 271-281
93. CARMELIET P; COLLEN D
    MOLECULAR-GENETICS OF THE FIBRINOLYTIC AND COAGULATION SYSTEMS IN HEMOSTASIS, THROMBOGENESIS, RESTENOSIS AND ATHEROSCLEROSIS
    Current opinion in lipidology
    
    P. Carmeliet e D. Collen, "MOLECULAR-GENETICS OF THE FIBRINOLYTIC AND COAGULATION SYSTEMS IN HEMOSTASIS, THROMBOGENESIS, RESTENOSIS AND ATHEROSCLEROSIS", Current opinion in lipidology, 8(2), 1997, pp. 118-125
94. CARMELIET P; COLLEN D
    MOLECULAR ANALYSIS OF BLOOD-VESSEL FORMATION AND DISEASE
    American journal of physiology. Heart and circulatory physiology
    
    P. Carmeliet e D. Collen, "MOLECULAR ANALYSIS OF BLOOD-VESSEL FORMATION AND DISEASE", American journal of physiology. Heart and circulatory physiology, 42(5), 1997, pp. 2091-2104
95. CARMELIET P; DIPALMA T; BARRA A; MOONS L; OOSTHUYZE B; BRUSSELMANS K; COLLEN D; PERSICO G
    IMPAIRED WOUND-HEALING IN MICE LACKING PLACENTAL GROWTH-FACTOR
    Thrombosis and haemostasis
    
    P. Carmeliet et al., "IMPAIRED WOUND-HEALING IN MICE LACKING PLACENTAL GROWTH-FACTOR", Thrombosis and haemostasis, 1997, pp. 642-642
96. CARMELIET P; MOONS L; DREW A; TIPPING P; LUPU F; LIJNEN HR; COLLEN D
    LACK OF ANEURYSM FORMATION IN ATHEROSCLEROTIC AORTA FROM UROKINASE DEFICIENT MICE
    Thrombosis and haemostasis
    
    P. Carmeliet et al., "LACK OF ANEURYSM FORMATION IN ATHEROSCLEROTIC AORTA FROM UROKINASE DEFICIENT MICE", Thrombosis and haemostasis, 1997, pp. 703-703
97. ROSEN E; CHAN JCY; IDUSOGIE E; CARMELIET P; CASTELLINO F; COLLEN D
    GENERATION AND CHARACTERIZATION OF FVII DEFICIENT MICE
    Thrombosis and haemostasis
    
    E. Rosen et al., "GENERATION AND CHARACTERIZATION OF FVII DEFICIENT MICE", Thrombosis and haemostasis, 1997, pp. 708-708
98. STELLA M; DIPIETRO N; DIODATO E; DOSSI C; NARDULLI A; DONATI MB; DEWERCHIN M; CARMELIET P; POGGI A
    REDUCED DISSEMINATION OF LEWIS LUNG-CARCINOMA IN MICE GENETICALLY DEFICIENT FOR UROKINASE-TYPE (U-PA) PLASMINOGEN-ACTIVATOR
    Thrombosis and haemostasis
    
    M. Stella et al., "REDUCED DISSEMINATION OF LEWIS LUNG-CARCINOMA IN MICE GENETICALLY DEFICIENT FOR UROKINASE-TYPE (U-PA) PLASMINOGEN-ACTIVATOR", Thrombosis and haemostasis, 1997, pp. 803-803
99. JALBERT LR; ROSEN ED; CARMELIET P; COLLEN D; CASTELLINO FJ
    NUCLEOTIDE STRUCTURE AND CHARACTERIZATION OF THE MURINE PROTEIN-C GENE FOR TARGETED GENE REPLACEMENT
    Thrombosis and haemostasis
    
    L.R. Jalbert et al., "NUCLEOTIDE STRUCTURE AND CHARACTERIZATION OF THE MURINE PROTEIN-C GENE FOR TARGETED GENE REPLACEMENT", Thrombosis and haemostasis, 1997, pp. 1700-1700
100. PLOPLIS V; BUSSUTIL S; FRENCH E; TANG L; CARMELIET P; COLLEN D; PLOW E
     THE INFLAMMATORY RESPONSE TO BIOPOLYMER IMPLANTS IN PLASMINOGEN DEFICIENT MICE
     Thrombosis and haemostasis
     
     V. Ploplis et al., "THE INFLAMMATORY RESPONSE TO BIOPOLYMER IMPLANTS IN PLASMINOGEN DEFICIENT MICE", Thrombosis and haemostasis, 1997, pp. 2234-2234